Table 4 Univariate linear mixed model analyses between the absolute variation of aqueous cytokines levels and anatomical and functional parameters.
Absolute variation of cytokine levels (pg/mL) | Absolute variation of anatomical and functional parameters | |||||
|---|---|---|---|---|---|---|
BCVA (logMAR) | CMT (µm) | Parafoveal SCPD (µm) | ||||
b(SE) | p-value | b(SE) | p-value | b(SE) | p-value | |
IL-1β | −0.250 (0.21) | 0.239 | 0.505 (0.34) | 0.136 | −0.890 (0.08) | 0.001 |
IL-1RA | 0.455 (0.19) | 0.025 | 0.526 (0.26) | 0.118 | −0.127 (0.14) | 0.726 |
IL-5 | 0.209 (0.10) | 0.326 | 0.207 (0.26) | 0.567 | 0.760 (0.21) | 0.010 |
IL-6 | −0.244 (0.21) | 0.251 | −0.177 (0.56) | 0.624 | 0.483 (0.19) | 0.017 |
IL-12p40 | 0.140 (0.18) | 0.515 | 0.065 (0.27) | 0.858 | 0.146 (0.05) | 0.686 |
IL-12p70 | 0.169 (0.22) | 0.430 | 0.729 (0.21) | 0.017 | −0.055 (0.14) | 0.880 |
VEGF | −0.420 (0.20) | 0.041 | 0.637 (0.31) | 0.047 | −0.729 (0.10) | 0.017 |
EOTAXIN | 0.305 (0.10) | 0.147 | 0.383 (0.22) | 0.274 | −0.395 (0.17) | 0.258 |
GRO | −0.105 (0.21) | 0.625 | 0.809 (0.25) | 0.005 | −0.298 (0.18) | 0.402 |
IP-10 | −0.048 (0.28) | 0.824 | 0.718 (0.21) | 0.019 | −0.940 (0.30) | <0.001 |
Fracktalkine | −0.143 (0.22) | 0.505 | 0.900 (0.66) | <0.001 | −0.529 (0.58) | 0.116 |
FLT-3L | 0.027 (0.01) | 0.901 | 0.449 (0.39) | 0.193 | 0.069 (0.14) | 0.849 |
